Activation-induced cytidine deaminase (AID), which is essential to both class switch recombination and somatic hypermutation of the Ig gene, is expressed in many types of human B cell lymphoma/ leukemia. AID is a potent mutator because it is involved in DNA breakage not only of Ig but also of other genes, including protooncogenes. Recent studies suggest that AID is required for chromosomal translocation involving cmyc and Ig loci. However, it is unclear whether AID plays other roles in tumorigenesis. We examined the effect of AID deficiency on the generation of surface Ig-positive B cell lymphomas in Emu-cmyc transgenic mice. Almost all lymphomas that developed in AID-deficient transgenic mice were pre-B cell lymphomas, whereas control transgenic mice had predominantly B cell lymphomas, indicating that AID is required for development of B but not pre-B cell lymphomas from cmyc overexpressing tumor progenitors. Thus, AID may play multiple roles in B cell lymphomagenesis.
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somatic hypermutation ͉ Pim1 ͉ secondary hit ͉ clonal expansion S omatic hypermutation (SHM) originally was considered to take place specifically in the IgV genes (1) . Subsequently, several genes other than those encoding Igs were shown to be targets of SHM in activated B cells and human B cell lymphomas. Such target genes include MYC, IG alpha, PAX5, BCL6, and PIM1 (2-4). Activation-induced cytidine deaminase (AID) has been shown to be essential for SHM, gene conversion, and class switch recombination (CSR), three types of genetic alteration induced by antigen stimulation of B lymphocytes (5) (6) (7) (8) (9) .
Original studies on human lymphomas indicated that AID is expressed in B cell lymphomas of germinal center (GC) origin, such as diffuse large B cell lymphoma, Burkitt's lymphoma, and follicular lymphoma, where AID is expressed physiologically (3, 10, 11) . However, more recent analyses have extended AID expression to other types of human B cell lymphoma, including chronic lymphocytic leukemia, Hodgkin's lymphoma, mantle cell lymphoma, mucosa-associated lymphoid tissue lymphoma, mediastinal B cell lymphoma, hairy cell leukemia, and acute lymphocytic leukemia (12) (13) (14) (15) (16) . The results of these studies suggest that AID may be involved in the pathogenesis of human B cell malignancy, including not only GC-derived B cell lymphoma but also almost all other types of human B cell lymphoma.
Studies on AID transgenic (Tg) animals have revealed that all individual mice develop T cell lymphomas in which genes for non-Igs such as T cell receptor (tcr), cmyc, pim1, cd4, and cd5 accumulate massive mutations in the region 3Ј proximal to each promoter (17, 18) . The AID Tg mice also develop B cell lymphoma, albeit much less frequently (I-m.O. and T.H., unpublished data). Studies also report AID to be essential for the mouse chromosomal translocation T(12;15), which corresponds to the human chromosomal translocation t (8;14) , the hallmark of endemic Burkitt's lymphoma, in IL-6 Tg mice (19, 20) . However, these animals did not develop plasmacytoma; instead, they developed polyclonal adenopathy (19) . By contrast, Unniraman et al. (21) reported that AID is not required for chromosomal translocation but is important for outgrowth of clones with the translocation in pristine-treated mice. However, Unniraman et al. did not explicitly assess tumor formation either. Therefore, a direct mechanistic link between AID and B cell lymphomagenesis has yet to be established.
It is believed that B cell lymphomagenesis requires not only overexpression of cmyc but also other genetic ''hits'' (22) . To examine the role of AID in B cell tumorigenesis, we studied the influence of AID deficiency on the generation of pre-B or B cell lymphomas in Emu-cmyc Tg mice. We found that AID deficiency induced a marked phenotypic change from predominantly B to predominantly pre-B cell lymphomas in Emu-cmyc Tg mice. We examined whether AID may facilitate the accumulation of the secondary genetic hits that are required for malignant transformation of cmyc-overexpressing B cell tumor progenitors in Emu-cmyc Tg animals. We found that Pim1, one of the targets of aberrant SHM in T lymphomas of AID Tg mice (18) , was mutated in B cell lymphoma but not in pre-B cell lymphoma. These results suggest that AID appears to facilitate the development of B cell lymphomas in cmyc Tg mice by introducing second hits.
Results and Discussion
Phenotypic Changes in Emu-cmyc Tg Tumors on AID ؉/؉ , AID ؉/؊ , and AID ؊/؊ Backgrounds. The survival curve of AID Ϫ/Ϫ Emu-cmyc Tg mice was similar (Fig. 1A) and AID ϩ/Ϫ Emu-cmyc Tg mice. In all cases, the lymph node architecture was completely destroyed. The predominant tumor cell was large and cleaved, and it had the appearance of an immunoblast: a large vesicular nucleus with prominent central nucleoli and a thick nuclear membrane, as reported in ref. 24 . This histological feature revealed that the tumor resembled the human immunoblastic type of large B cell lymphoma or immunoblastic lymphoma in the Revised European-American Classification of Lymphoid Neoplasms (REAL classification).
The lymphomas that developed in Emu-cmyc Tg mice were categorized into pre-B and B cell lymphomas, depending on surface Ig expression (24, 25) . The pre-B and B cell lymphomas were defined in this report by B220 (26) (27) (28) . The B cell lymphomas expressed IgM, IgG, or IgA. The IgD was expressed on many but not all IgM ϩ B cell lymphomas ( Fig. 1B and Table 1 ). The majority (6/8) of tumors in Emu-cmyc Tg AID ϩ/ϩ mice were B cell lymphomas, with the remaining being pre-B cell lymphomas. These results are in good agreement with the previous report that 70% of the tumors in Emu-cmyc Tg mice were B cell lymphomas, with the remaining tumors being pre-B cell lymphomas (25) . In contrast, almost all lymphomas (9/10) in AID Ϫ/Ϫ Emu-cmyc Tg mice were pre-B cell lymphomas.
Interestingly, the proportion of B and pre-B (including pro-B) cell lymphomas in AID ϩ/Ϫ Emu-cmyc Tg mice was 1:1 (7/14). One lymphoma was classified as pro-B lymphoma because of its expression of the CD43 antigen (29) . The relative decrease of B cell lymphomas in AID ϩ/Ϫ Emu-cmyc Tg mice compared with AID ϩ/ϩ Emu-cmyc Tg mice suggests that AID may have weak haploinsufficiency in the development of B cell lymphoma. (Fig. 1C and Table 1 ). Because expression of bcl6 and occasional CSR in some B cell lymphomas in Emu-cmyc Tg mice indicates that they are derived from GC/post-GC B cells (33) , the V regions in the heavy chain were sequenced to detect SHM. Unexpectedly, the V regions in seven B cell lymphomas from Emu-cmyc Tg mice did not have SHM at all ( Table 2 ). The occurrence of CSR, expression of bcl6, and unmutated V regions provide conflicting results to define the tumor origin in the normal scheme of B cell development (34) (35) (36) . However, recent studies have revealed that the discrepancy among the incidence of CSR, bcl6 expression, and SHM can happen in pathophysiological conditions. In T cell-independent manners, CSR can occur without SHM at non-GC sites, such as the extrafollicular site (37) . The subgroup of human chronic lymphocytic leukemia with unmutated V regions undergoes active CSR (16) . Burkitt-like lymphoma cells developing in cmyc knockin mice express bcl6 but do not show SHM in the V regions, which indicates that deregulated expression of cmyc induces expression of bcl6 in cells negative for Ig SHM (38) . Most importantly, AID can be expressed even in Ig SHM-negative B lymphomas, regardless of whether they derive from GC or non-GC cells (10, (12) (13) (14) (15) (16) 39) . (2) (3) (4) 40) . Of these, we focused on Pim1 because it has been reported to act synergistically with cmyc in lymphomagenesis (41) and because we previously found missense mutations in pim1 in the T cell lymphoma of AID Tg mice (18) . We determined the nucleotide sequence (848 bp) covering exons 1 through 4 in 10 B cell lymphomas derived from AID ϩ/ϩ and AID ϩ/Ϫ Emu-cmyc Tg mice. We found one missense mutation (S138P) and three silent mutations (720 G to A), whereas pre-B cell lymphomas from eight mice showed no mutations ( Table 2 ). These mutations are not polymorphisms because we identified the mutations by comparing lymphoma sequences with the genomic sequence of the tails of the identical mouse. The locations of the mutations were the same as those found in T cell lymphomas of AID Tg mice (18) . Although it has not been determined whether these mutations in pim1 conveyed a survival advantage, there is no doubt that the Pim1 gene was one of the SHM targets in B lymphomas. It therefore is possible that these clones might have accumulated mutations in other Some B cell lymphomas in Emu-cmyc Tg mice had the unmutated V region and mutated Pim1 genes (nos. 28, 112, and 162). Under physiological conditions, IgV genes are the preferred targets of the SHM machinery over other oncogenes (3) . However, this preference may not be applicable in lymphomas. A subgroup of chronic lymphocytic leukemia has been reported to have mutated bcl6 but unmutated IgV genes (42) . Aberrant mutations in non-Ig genes could be enhanced by overexpression of cmyc. Supporting information (SI) Table  3 shows the results of spectral karyotyping analyses of the lymphomas that developed in AID ϩ/ϩ , AID ϩ/Ϫ , and AID
Ϫ/Ϫ
Emu-cmyc Tg mice. These analyses indicated that none of the lymphomas from the three genetic backgrounds had apparent chromosomal translocations.
Model for the Involvement of AID in B Cell Lymphomagenesis. Chromosomal translocations involving cmyc have been suggested to be the triggering but not sufficient event in the development of lymphoma (22, 24, 43) . It is likely that B lineage cells in Emu-cmyc Tg mice require several additional genetic alterations for lymphomagenesis. The absence of drastic differences in the survival period among AID ϩ/ϩ , AID ϩ/Ϫ , and AID Ϫ/Ϫ Emu-cmyc Tg mice indicates that AID does not augment the overall efficiency of tumorigenesis. In other words, the rate-limiting step of tumorigenesis resides before AID expression. Because Tg cmyc is expressed at or before the pre-B stage, tumor progenitors are likely to arise slowly at the pre-B cell stage. Pre-B cell lymphomas do not depend on AID, which is in agreement with the fact that AID expression has not been shown in pre-B cells, although a very low level of AID was reported to be expressed in immature B cells (10, 44) . Pre-B cell tumor progenitors can differentiate into the B cell stage, as reported in ref. 24 . Because AID is required for formation of B cell lymphoma, AID may give additional genetic alterations in B cell tumor progenitors and facilitate outgrowth of B cell lymphomas. Otherwise, B cell Table 1 . Phenotypical analysis of lymphomas in AID ؉/؉ , AID ؉/؊ , and AID ؊/؊ Emu-cmyc Tg mice
B220, Bp1, and IgM were considered positive when they were expressed in Ͼ50% of tumor cells by FACS. IgA, IgD, and bcl6 were considered positive when they were expressed in Ͼ20% of tumor cells by FACS (IgA and IgD) or immunohistochemistry (bcl6). AID was positive when mRNA expression of AID was Ͼ10% of that found in the total spleen cells by real-time PCR. ND, not determined. tumor progenitors may die out without expansion (Fig. 2) . By contrast, tumor progenitors at the pre-B cell stage may gain a final genetic hit spontaneously to grow out selectively and fix tumorigenesis. This phenomenon occurs because pre-B cells proliferate four to eight times faster than B cells do, and this phenomenon is enhanced further by aberrant cmyc expression (45) . Because AID is critically involved in chromosomal translocation, as reported recently by Ramiro et al. (20) , AID may have dual functions in B cell lymphoma development: initiation by chromosomal translocation and clonal expansion by mutagenesis. Because of its multiple functions in B cell lymphoma development, AID could become a useful therapeutic target.
Methods
Mice. AID-deficient mice (C57BL/6) were interbred with Emucmyc Tg mice (24) (inbred C57BL/6 strain; kindly provided by Alan Harris, The Walter and Eliza Hall Institute of Medical Research, Melbourne PO Royal Hospital, Victoria, Australia). The offspring were intercrossed to obtain AID ϩ/ϩ , AID ϩ/Ϫ , and AID Ϫ/Ϫ Emu-myc Tg littermates. Kaplan-Meier curves represent the percentage of overall survival. The log-rank test was used to determine the statistical significance of differences in survival between the different genotypes of Emu-cmyc Tg mice. All mouse protocols were approved by the Institute of Laboratory Animals, Faculty of Medicine, Kyoto University. The genomic location of the mutations in Pim1 is numbered from the starting site of exon 1 (chromosome 17 at 29, 217, 824). The location of the amino acid substitution in Pim1 protein is numbered from the translational starting site (ENSMUSP00000024811). The genomic region for sequence analysis is that from chromosome 17 from 29, 218, 046 to 29, 218, 893. ND, not determined. *Analyzed by RT-PCR.
† Homology to rearranged VH segments in the IgBLAST database (www.ncbi.nlm.nih.gov/igblast).
tron-R, 5Ј-CTCCACCAGACCTCTCTAGAC-3Ј. The PCR conditions were 35 cycles of 94°C for 30 sec, 66°C for 30 sec, and 72°C for 1 min for Pim1 and 35 cycles of 94°C for 30 sec, 63°C for 30 sec, and 72°C for 2 min for VH. The Ig gene cDNA templates were amplified with 3Ј primer corresponding to constant regions of expressed Ig genes and degenerate 5Ј primers to variable regions. Primers were as follows: Cmm-R, 5Ј-CCCGA AT TCGCTCTCGCAGGAGAC-3Ј; VH1-F, 5Ј-CCCGA AT TCGAGGTGA AGCTGGTGGAGWC-3Ј; and VH2-F, 5Ј-CCCGAATTCCAGGTCCAGTTGCAGCAGWC-3Ј. PCR conditions were 30 cycles of 94°C for 30 sec, 60°C for 30 sec, and 72°C for 1 min. PCR products were gel-purified by using a PCR purification kit (Promega, Madison, WI) and sequenced directly on an ABI3700 sequencer (Applied Biosystems, Foster City, CA).
